Encision Inc. (ECIA)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.98 Million USD | 21.05% |
| 2023 | 1.63 Million USD | -19.89% |
| 2022 | 2.04 Million USD | -28.39% |
| 2021 | 2.85 Million USD | 11.91% |
| 2020 | 2.55 Million USD | 137.25% |
| 2019 | 1.07 Million USD | 2.68% |
| 2018 | 1.04 Million USD | -17.15% |
| 2017 | 1.26 Million USD | -6.16% |
| 2016 | 1.34 Million USD | -7.54% |
| 2015 | 1.45 Million USD | -10.17% |
| 2014 | 1.62 Million USD | 2.14% |
| 2013 | 1.58 Million USD | -4.99% |
| 2012 | 1.67 Million USD | 0.94% |
| 2011 | 1.65 Million USD | -3.45% |
| 2010 | 1.71 Million USD | 0.39% |
| 2009 | 1.7 Million USD | -15.21% |
| 2008 | 2.01 Million USD | 37.67% |
| 2007 | 1.46 Million USD | 34.87% |
| 2006 | 1.08 Million USD | -4.2% |
| 2005 | 1.13 Million USD | 32.69% |
| 2004 | 854 Thousand USD | -7.85% |
| 2003 | 926.78 Thousand USD | 44.64% |
| 2002 | 640.75 Thousand USD | 12.81% |
| 2001 | 567.98 Thousand USD | 18.83% |
| 2000 | 477.98 Thousand USD | -4.47% |
| 1999 | 500.35 Thousand USD | 9.18% |
| 1998 | 458.28 Thousand USD | -53.35% |
| 1997 | 982.34 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.31 Million USD | 49.61% |
| 2024 Q1 | 1.54 Million USD | -5.55% |
| 2024 FY | 1.98 Million USD | 21.05% |
| 2024 Q3 | 2.09 Million USD | -9.61% |
| 2024 Q4 | 1.98 Million USD | -5.23% |
| 2023 Q3 | 1.52 Million USD | -16.12% |
| 2023 Q1 | 1.79 Million USD | -12.22% |
| 2023 FY | 1.63 Million USD | -19.89% |
| 2023 Q4 | 1.63 Million USD | 7.69% |
| 2023 Q2 | 1.81 Million USD | 1.03% |
| 2022 Q1 | 2.84 Million USD | -0.32% |
| 2022 Q2 | 2.49 Million USD | -12.5% |
| 2022 Q3 | 2.14 Million USD | -14.04% |
| 2022 Q4 | 2.04 Million USD | -4.48% |
| 2022 FY | 2.04 Million USD | -28.39% |
| 2021 FY | 2.85 Million USD | 11.91% |
| 2021 Q2 | 3.21 Million USD | 11.44% |
| 2021 Q1 | 2.88 Million USD | 13.0% |
| 2021 Q4 | 2.85 Million USD | 16.37% |
| 2021 Q3 | 2.45 Million USD | -23.64% |
| 2020 Q4 | 2.55 Million USD | 11.58% |
| 2020 Q2 | 1.93 Million USD | -10.8% |
| 2020 Q3 | 2.28 Million USD | 18.37% |
| 2020 FY | 2.55 Million USD | 137.25% |
| 2020 Q1 | 2.16 Million USD | 101.38% |
| 2019 Q4 | 1.07 Million USD | -4.09% |
| 2019 Q3 | 1.12 Million USD | 5.75% |
| 2019 Q1 | 1.04 Million USD | -0.19% |
| 2019 FY | 1.07 Million USD | 2.68% |
| 2019 Q2 | 1.06 Million USD | 1.43% |
| 2018 Q1 | 1.13 Million USD | -10.67% |
| 2018 Q3 | 1.02 Million USD | 3.65% |
| 2018 Q4 | 1.04 Million USD | 2.44% |
| 2018 FY | 1.04 Million USD | -17.15% |
| 2018 Q2 | 987 Thousand USD | -12.65% |
| 2017 Q2 | 1.23 Million USD | -7.02% |
| 2017 Q3 | 1.32 Million USD | 7.63% |
| 2017 FY | 1.26 Million USD | -6.16% |
| 2017 Q1 | 1.32 Million USD | -1.71% |
| 2017 Q4 | 1.26 Million USD | -4.6% |
| 2016 Q4 | 1.34 Million USD | 8.97% |
| 2016 FY | 1.34 Million USD | -7.54% |
| 2016 Q1 | 1.28 Million USD | -11.66% |
| 2016 Q2 | 1.08 Million USD | -15.84% |
| 2016 Q3 | 1.23 Million USD | 14.11% |
| 2015 Q4 | 1.45 Million USD | -4.64% |
| 2015 FY | 1.45 Million USD | -10.17% |
| 2015 Q2 | 1.37 Million USD | -1.08% |
| 2015 Q1 | 1.39 Million USD | -14.36% |
| 2015 Q3 | 1.52 Million USD | 11.2% |
| 2014 Q1 | 2.09 Million USD | 31.84% |
| 2014 FY | 1.62 Million USD | 2.14% |
| 2014 Q4 | 1.62 Million USD | 19.69% |
| 2014 Q3 | 1.35 Million USD | -29.01% |
| 2014 Q2 | 1.91 Million USD | -8.83% |
| 2013 Q4 | 1.58 Million USD | 4.54% |
| 2013 Q2 | 1.41 Million USD | 19.75% |
| 2013 Q1 | 1.18 Million USD | -29.14% |
| 2013 FY | 1.58 Million USD | -4.99% |
| 2013 Q3 | 1.52 Million USD | 7.12% |
| 2012 Q1 | 1.99 Million USD | 20.13% |
| 2012 Q4 | 1.67 Million USD | -39.13% |
| 2012 FY | 1.67 Million USD | 0.94% |
| 2012 Q2 | 2.26 Million USD | 14.01% |
| 2012 Q3 | 2.74 Million USD | 21.08% |
| 2011 Q4 | 1.65 Million USD | 13.28% |
| 2011 Q3 | 1.46 Million USD | -15.66% |
| 2011 FY | 1.65 Million USD | -3.45% |
| 2011 Q2 | 1.73 Million USD | -8.32% |
| 2011 Q1 | 1.89 Million USD | 10.27% |
| 2010 Q1 | 1.6 Million USD | -5.93% |
| 2010 Q3 | 1.37 Million USD | -14.81% |
| 2010 FY | 1.71 Million USD | 0.39% |
| 2010 Q2 | 1.61 Million USD | 0.19% |
| 2010 Q4 | 1.71 Million USD | 25.0% |
| 2009 Q2 | 1.79 Million USD | 2.51% |
| 2009 Q4 | 1.7 Million USD | 9.75% |
| 2009 Q3 | 1.55 Million USD | -13.1% |
| 2009 FY | 1.7 Million USD | -15.21% |
| 2009 Q1 | 1.74 Million USD | -13.26% |
| 2008 Q1 | 1.56 Million USD | 6.66% |
| 2008 FY | 2.01 Million USD | 37.67% |
| 2008 Q3 | 1.77 Million USD | 1.65% |
| 2008 Q4 | 2.01 Million USD | 13.58% |
| 2008 Q2 | 1.74 Million USD | 11.8% |
| 2007 FY | 1.46 Million USD | 34.87% |
| 2007 Q3 | 1.44 Million USD | 13.83% |
| 2007 Q1 | 1.23 Million USD | 13.5% |
| 2007 Q4 | 1.46 Million USD | 1.09% |
| 2007 Q2 | 1.27 Million USD | 3.27% |
| 2006 Q4 | 1.08 Million USD | -13.24% |
| 2006 Q1 | 1.21 Million USD | 6.82% |
| 2006 Q3 | 1.25 Million USD | 13.31% |
| 2006 Q2 | 1.1 Million USD | -8.77% |
| 2006 FY | 1.08 Million USD | -4.2% |
| 2005 FY | 1.13 Million USD | 32.69% |
| 2005 Q3 | 961.7 Thousand USD | -1.95% |
| 2005 Q1 | 1.15 Million USD | 35.42% |
| 2005 Q4 | 1.13 Million USD | 17.83% |
| 2005 Q2 | 980.8 Thousand USD | -15.19% |
| 2004 Q2 | 861.98 Thousand USD | 1.39% |
| 2004 FY | 854 Thousand USD | -7.85% |
| 2004 Q3 | 904.65 Thousand USD | 4.95% |
| 2004 Q4 | 854 Thousand USD | -5.6% |
| 2004 Q1 | 850.12 Thousand USD | -8.27% |
| 2003 Q2 | 842.88 Thousand USD | 37.97% |
| 2003 FY | 926.78 Thousand USD | 44.64% |
| 2003 Q4 | 926.78 Thousand USD | -6.23% |
| 2003 Q3 | 988.37 Thousand USD | 17.26% |
| 2003 Q1 | 610.9 Thousand USD | -4.66% |
| 2002 Q1 | 650.81 Thousand USD | 14.58% |
| 2002 Q2 | 840.38 Thousand USD | 29.13% |
| 2002 FY | 640.75 Thousand USD | 12.81% |
| 2002 Q4 | 640.75 Thousand USD | 0.39% |
| 2002 Q3 | 638.3 Thousand USD | -24.05% |
| 2001 Q3 | 499.56 Thousand USD | 1.61% |
| 2001 FY | 567.98 Thousand USD | 18.83% |
| 2001 Q2 | 491.64 Thousand USD | -10.17% |
| 2001 Q4 | 567.98 Thousand USD | 13.7% |
| 2001 Q1 | 547.3 Thousand USD | 14.5% |
| 2000 Q4 | 477.98 Thousand USD | 7.63% |
| 2000 Q3 | 444.11 Thousand USD | 0.0% |
| 2000 FY | 477.98 Thousand USD | -4.47% |
| 1999 FY | 500.35 Thousand USD | 9.18% |
| 1998 FY | 458.28 Thousand USD | -53.35% |
| 1997 FY | 982.34 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | 15.57% |
| Ansell Limited | 1.32 Billion USD | 99.851% |
| Ansell Limited | 1.33 Billion USD | 99.851% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 98.43% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -110.351% |
| Psykey, Inc. | 2.47 Million USD | 19.808% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.902% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.902% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 34.748% |
| Innovative MedTech Inc. | 6.13 Million USD | 67.661% |
| LifePoint, Inc. | 2.45 Million USD | 19.159% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 80.513% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 41.648% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 34.745% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -155.558% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.798% |
| Sector 10, Inc. | 9.84 Million USD | 79.849% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.854% |
| SheerVision, Inc. | 1.43 Million USD | -38.603% |
| United Health Products, Inc. | 1.99 Million USD | 0.745% |
| Vasamed, Inc. | 1 Million USD | -97.351% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 47.794% |
| Yubo International Biotech Limited | 2.91 Million USD | 31.914% |